fool.com
Positivewww.fool.com ·
herbalife hlf q1 2026 earnings transcript
TAX_DISEASE_DIABETESTAX_CHRONICDISEASE_DIABETESWB_1406_DISEASESWB_1433_DIABETES
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedHerbalife's Q1 earnings show strong India growth offsetting North America/China weakness. The refinancing directly improves interest expense and net income. Impact is company-specific (Herbalife) with regional exposure to India (emerging market). No commodity or broad sector price signal.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Q1 2026 net sales $1.3B, +7.8% YoY
- India record sales $275M, +32% YoY
- Refinanced $1.45B debt, saving ~$45M annual interest
- Adjusted EBITDA $176M, 13.3% margin
- Full-year net sales growth outlook 1.5%-5.5%